ReviewRSC advances2019
Green synthesis of silver nanoparticles: biomolecule-nanoparticle organizations targeting antimicrobial activity.
Review in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 270 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
270 citing papers in PubMed, 1 synthesis or guideline pooled it, 1,010 citations in OpenAlex.
- Systematic Review on Biosynthesis of Silver Nanoparticles and Antibacterial Activities: Application and Theoretical Perspectives.Molecules (Basel, Switzerland) · 2021Pooled it
- Targeting Dengue Viral Proteins with Eco-Friendly Nanotechnology: A Promising Path for Antiviral Research.Viruses · 2026Review
- Nostoc sp.-mediated silver nanoparticles: biosynthesis, characterization, antibacterial activity, and cytocompatibility assessment.Archives of microbiology · 2026Article
- Silver Nanoparticles fromACS omega · 2026Article
- Are Silver and Gold Nanoparticles Obtained by 'Green' Synthesis Biocompatible?Nanomaterials (Basel, Switzerland) · 2026Review
- Bactericidal multilayer fibrous titanium phosphate nanocomposites with embedded silver nanoparticles by optimized "green" synthesis.RSC advances · 2026Article
- Fungicidal Activity of Silver Nanoparticles Synthesized Using Lithospermum erythrorhizon against Fusarium spp. In Vitro and In Planta.Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2026Article
- Surface modification of urinary catheters with antibiofilm nanocoating: curcumin modified silver nanoparticles against Proteus mirabilis.Journal of materials science. Materials in medicine · 2026Article
- Green synthesis of silver nanoparticles using Achillea arabica and their antioxidant, anti-inflammatory, antidiabetic, and antimicrobial activities.Discover nano · 2026Article
- Facile synthesis of Sarcochlamys pulcherrima mediated silver nanoparticles for antibacterial, antibiofilm, and network pharmacology evaluation.Scientific reports · 2026Article
- Green synthesis of silver nanoparticles using Solanum melongena peel and Abelmoschus esculentus extracts: a dual study on antibacterial efficacy and photocatalytic activity.Scientific reports · 2026Article
- Green synthesis of nisin-loaded pectin based silver nanoparticles and their antimicrobial and biosafety assessment.Discover nano · 2026Article
- Antimicrobial potential of silver nanoparticles synthesized from mushroom extracts against drug-resistant pathogens.New microbes and new infections · 2026Article
- Innovative Approaches to Combat Antimicrobial Resistance: A Review of Emerging Therapies and Technologies.Probiotics and antimicrobial proteins · 2026Review
- Green synthesized silver and zinc oxide nanoparticles with antifungal, DNA protection, DNA cleavage, and cytotoxic activities.Scientific reports · 2026Article
- Postharvest delivery of Bacillus G36 metabolites formulated in AgNP modifies Salvia rosmarinus Spenn. bioactive profiles.Scientific reports · 2026Article
- Green synthesis of silver nanoparticles withRSC advances · 2026Article
- Biogenesis of Au Nanoparticles from Plant-Derived Metabolites -ACS biomaterials science & engineering · 2026Article
- Green synthesis of silver nanoparticles using fermentation extracts from a mangrove soil bacterium: morphological characterization, and antifungal activities against rice blast fungus.Pest management science · 2026Article
- Bacterial-engineered self-stabilizing ultra-small AgCu nanoparticles for dual antimicrobial-anticancer therapy.Bioactive materials · 2026Article
210 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since discovery of the first antibiotic drug, penicillin, in 1928, a variety of antibiotic and antimicrobial agents have been developed and used for both human therapy and industrial applications. However, excess and uncontrolled use of antibiotic agents has caused a significant growth in the number of drug resistant pathogens. Novel therapeutic approaches replacing the inefficient antibiotics are in high demand to overcome increasing microbial multidrug resistance. In the recent years, ongoing research has focused on development of nano-scale objects as efficient antimicrobial therapies. Among the various nanoparticles, silver nanoparticles have gained much attention due to their unique antimicrobial properties. However, concerns about the synthesis of these materials such as use of precursor chemicals and toxic solvents, and generation of toxic byproducts have led to a new alternative approach, green synthesis. This eco-friendly technique incorporates use of biological agents, plants or microbial agents as reducing and capping agents. Silver nanoparticles synthesized by green chemistry offer a novel and potential alternative to chemically synthesized nanoparticles. In this review, we discuss the recent advances in green synthesis of silver nanoparticles, their application as antimicrobial agents and mechanism of antimicrobial mode of action.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.